Clonal accumulation of Vβ5.1-positive cells in the liver of a patient with autoimmune cholangiopathy

Liver

Volumn 17, Issue 1, 1997, Pages 7-12

  Shimizu, Yukihiro ^a   Higuchi, Kiyohiro ^a   Kashii, Yoshirou ^a   Miyamoto, Megumi ^a   Tsukishiro, Takashi ^a   Watanabe, Akiharu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Autoimmune cholangiopathy; T cell response

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; MITOCHONDRION ANTIBODY; T LYMPHOCYTE RECEPTOR; URSODEOXYCHOLIC ACID;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; BILE DUCT DISEASE; CASE REPORT; CELL TYPE; ENZYME ACTIVITY; ETIOLOGY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIVER BIOPSY; LIVER FUNCTION TEST; T LYMPHOCYTE; TISSUE DISTRIBUTION;

EID: 0031044074     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1997.tb00771.x     Document Type: Article

References (23)

1. SHERLOCK S, DOOLEY J C. Primary biliary cirrhosis. In: Diseases of the liver and biliary systems. 9th edn. Oxford: Blackwell Scientific Publications, 1992: 238-248.
2. MACKAY I R. Pathogenesis of autoimmune chronic active hepatitis. In: KRAWITZ E L, WEINER R H, eds. Autoimmune liver disease. New York: Raven Press, 1991: 21-42.
3. BRUNNER G, KLINGE O. A cholangitis with antinuclear antibodies (immunocholangitis) resembling chronic non-suppurative destructive cholangitis. Dtsch Med Wochenschr 1987: 112: 1454-1458.
4. CARROUGHER J G, SHAFFER R T, CANALES L I, GOODMAN Z D. A 33-year-old woman with an autoimmune syndrome. Semin Liver Dis 1991: 11: 256-262.
5. POPPER H, SHAFFNER F. Nonsuppurative destructive chronic cholangitis and chronic hepatitis. Prog Liver Dis 1970: 8: 336-354.
6. OKUNO T, SETO Y, OKANOUE T, TAKINO T. Chronic active hepatitis with histological features of primary biliary cirrhosis. Dig Dis Sci 1987: 32: 775-779.
7. MICHIELETTI P, WANLESS I R, KATZ A, et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 1994: 35: 260-265.
8. BEN-ARI Z, DHILLON A P, SHERLOCK S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993; 18: 10-15.
9. SCHEUER P J, LEEKOWITCH J H. Primary biliary cirrhosis. In: Liver biopsy interpretation. 5th edn. London: W.B. Saunders Company Ltd, 1994: 51-61.
10. DAVIS M M, BJORKMAN P J. T-cell antigen receptor genes and T-cell recognition. Nature 1988: 334: 395-402.
11. OKSENBERG J R, STUART S, BEGOVICH A B, et al. Limited heterogeneiety of rearranged T cell receptor Va transcripts in brains of multiple sclerosis patients. Nature 1990: 345: 344-346.
12. DAVIS T F, MARTIN A, CONCEPCION E S, GRAVES P, COHEN L. BEN-NUN A. Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med 1991: 325: 238-244.
13. POSNETT D N, SCHMELKIN I, BURTON D A, AUGUST A, McGRATH H, MAYER L F. T cell antigen receptor V gene usage. Increase in Vβ8+ T cells in Crohn's disease. J Clin Invest 1990: 85: 1770-1776.
14. JOHNSON P J, MCFARLANE I G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993: 18: 998-1005.
15. MITCHISON H C, PALMER J M, BASSENDINE M F, WATSON A J, RECORD C O, JAMES O F W. A controlled trial of prednisolone treatment in primary biliary cirrhosis: three-year results. J Hepatol 1992: 15: 336-344.
16. FLORA K, BENNER K, LEE R, FENNIMORE S. Primary autoimmune cholangitis as an early variant of primary biliary cirrhosis. Hepatology 1994: 20: 152A.
17. JOHNSON P J, MCFARLANE I G, EDDLESTON A L W F. The natural course and heterogeneity of autoimmune type chronic active hepatitis. Semin Liver Dis 1991: 11: 187-196.
18. COLOMBATO L A, ALVAREZ F, COTE J, HUET P-M. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis. Gastroenterology 1994: 107: 1839-1843.
19. WEIDMANN E, WHITESIDE T L, GIORDA R, HERBERMAN R B, TRUCCO M. The T-cell receptor Vβ gene usage in tumorinfiltrating lymphocytes and blood of patients with hepatocellular carcinoma. Cancer Res 1992: 52: 5913-5920.
20. LEHMANN P V, FORSTHUBER T, MILLER A, SERCARZ E E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992: 358: 155-157.
21. TAKANO S, ITO Y, YOKOSUKA O, et al. A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C. Hepatology 1994: 20: 558-564.
22. CALMUS Y, GANE P, ROUGER P, POUPON R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis effect of ursodeoxycholic acid. Hepatology 1990: 11: 12-15.
23. LACAILLE F, KHAZAL P. The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells. Hepatology 1993: 18: 165-172.